
Regulation
TrumpRx Drug List Analysis: 50% Have Cheaper Alternatives, Raising Questions About Cost-Effectiveness
2/6/2026

Business
TrumpRx Enters Prescription Discount Market: Pricing Analysis and Market Implications
2/6/2026

Business
Xi Jinping and Keir Starmer Meet as AstraZeneca Commits $15 Billion to China
1/29/2026